# Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

Study · id `cardio:ct-nct01776788` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01776788](<https://clinicaltrials.gov/study/NCT01776788>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01776788

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.

## Technical summary

Registry record NCT01776788. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 156 participants (enrolled count; ClinicalTrials.gov record NCT01776788, source copy `cardio:ctgov-nct01776788-2015-03-10`, retrieved 2026-10-26)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01776788, source copy `cardio:ctgov-nct01776788-2015-03-10`, retrieved 2026-10-26)
- Primary completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01776788, source copy `cardio:ctgov-nct01776788-2015-03-10`, retrieved 2026-10-26)
- Completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01776788, source copy `cardio:ctgov-nct01776788-2015-03-10`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01776788, source copy `cardio:ctgov-nct01776788-2015-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01776788-2015-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): insulin lispro injection, exenatide injection
- Intervention (Drug): insulin lispro injection
- Lead sponsor: The First Affiliated Hospital of Xiamen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: e50ade43b3798bb21943f4b594ec27d713e0a30db0d02ae1712a000814c5b3d8
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
